Asparaginase for Injection is an enzyme based anticancer therapy specifically designed to target metabolic pathways essential for the survival of certain leukemia cells. By lowering circulating asparagine levels, it disrupts protein production within malignant cells, leading to inhibited tumor growth. Its proven efficacy in combination chemotherapy regimens has made it a foundational treatment...